Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Timothy P. Clackson currently holds 35,000 shares of Spring Bank Pharmaceuticals, Inc. (SBPH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Timothy P. Clackson has been a net seller of SBPH stock. They have purchased $79.4K and sold $11.8M worth of shares.
Timothy P. Clackson's most recent insider trade was on Jul 23, 2025, when they sold 47,330 shares at $0.36 per share.
Timothy P. Clackson serves as Executive at Spring Bank Pharmaceuticals, Inc. (SBPH). They have executed 132 insider transactions totaling $11.9M over their tenure at the company.
Timothy P. Clackson holds the position of Executive at Spring Bank Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Timothy P. Clackson has shown a selling trading pattern, with $79.4K in total purchases and $11.8M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Timothy P. Clackson was on Sep 15, 2016, when they sold $696.4K worth of ARIA shares. This transaction involved 59,369 shares at $11.73 per share.
Timothy P. Clackson currently owns 35,000 shares of Spring Bank Pharmaceuticals, Inc. (SBPH), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Timothy P. Clackson's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Timothy P. Clackson has 132 Form 4 filings on record as an insider at Spring Bank Pharmaceuticals, Inc..
Set alerts for Timothy P. Clackson and 40,000+ other insiders.